COVID-19 Impact on Global Diabetic Neurological Disorder Therapeutic Drug Market Size, Status and Forecast 2020-2026

August 2020 | 94 pages | ID: C1895A267CE2EN
QYResearch

Abstracts

This report focuses on the global Diabetic Neurological Disorder Therapeutic Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Neurological Disorder Therapeutic Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AstraZeneca
• Johnson & Johnson
• Takeda
• Mitsubishi Chemical
• Avanir Pharmaceuticals
• Dong-A Pharmaceutical Co., Ltd.
• Immune Pharmaceuticals
• MediciNova
• Sangamo BioSciences

Market segment by Type, the product can be split into

• Capsule
• Pills
• Other

Market segment by Application, split into

• Symmetrical Neuropathy
• Focal and Multifocal Neuropathy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Diabetic Neurological Disorder Therapeutic Drug status, future forecast, growth opportunity, key market and key players.
• To present the Diabetic Neurological Disorder Therapeutic Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Diabetic Neurological Disorder Therapeutic Drug are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetic Neurological Disorder Therapeutic Drug Revenue
1.4 Market Analysis by Type
  1.4.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Capsule
  1.4.3 Pills
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application: 2020 VS 2026
  1.5.2 Symmetrical Neuropathy
  1.5.3 Focal and Multifocal Neuropathy
1.6 Coronavirus Disease 2019 (Covid-19): Diabetic Neurological Disorder Therapeutic Drug Industry Impact
  1.6.1 How the Covid-19 is Affecting the Diabetic Neurological Disorder Therapeutic Drug Industry
    1.6.1.1 Diabetic Neurological Disorder Therapeutic Drug Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Diabetic Neurological Disorder Therapeutic Drug Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Diabetic Neurological Disorder Therapeutic Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Diabetic Neurological Disorder Therapeutic Drug Market Perspective (2015-2026)
2.2 Diabetic Neurological Disorder Therapeutic Drug Growth Trends by Regions
  2.2.1 Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Diabetic Neurological Disorder Therapeutic Drug Historic Market Share by Regions (2015-2020)
  2.2.3 Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Diabetic Neurological Disorder Therapeutic Drug Market Growth Strategy
  2.3.6 Primary Interviews with Key Diabetic Neurological Disorder Therapeutic Drug Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Market Size
  3.1.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue (2015-2020)
  3.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Players (2015-2020)
  3.1.3 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio
  3.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2019
3.3 Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Area Served
3.4 Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
3.5 Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Type (2015-2020)
4.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2021-2026)

5 DIABETIC NEUROLOGICAL DISORDER THERAPEUTIC DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020)
5.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size (2015-2020)
6.2 Diabetic Neurological Disorder Therapeutic Drug Key Players in North America (2019-2020)
6.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020)
6.4 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size (2015-2020)
7.2 Diabetic Neurological Disorder Therapeutic Drug Key Players in Europe (2019-2020)
7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020)
7.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020)

8 CHINA

8.1 China Diabetic Neurological Disorder Therapeutic Drug Market Size (2015-2020)
8.2 Diabetic Neurological Disorder Therapeutic Drug Key Players in China (2019-2020)
8.3 China Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020)
8.4 China Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Diabetic Neurological Disorder Therapeutic Drug Market Size (2015-2020)
9.2 Diabetic Neurological Disorder Therapeutic Drug Key Players in Japan (2019-2020)
9.3 Japan Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020)
9.4 Japan Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size (2015-2020)
10.2 Diabetic Neurological Disorder Therapeutic Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020)

11 INDIA

11.1 India Diabetic Neurological Disorder Therapeutic Drug Market Size (2015-2020)
11.2 Diabetic Neurological Disorder Therapeutic Drug Key Players in India (2019-2020)
11.3 India Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020)
11.4 India Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Diabetic Neurological Disorder Therapeutic Drug Market Size (2015-2020)
12.2 Diabetic Neurological Disorder Therapeutic Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020)
12.4 Central & South America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AstraZeneca
  13.1.1 AstraZeneca Company Details
  13.1.2 AstraZeneca Business Overview and Its Total Revenue
  13.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Introduction
  13.1.4 AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020))
  13.1.5 AstraZeneca Recent Development
13.2 Johnson & Johnson
  13.2.1 Johnson & Johnson Company Details
  13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Introduction
  13.2.4 Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
  13.2.5 Johnson & Johnson Recent Development
13.3 Takeda
  13.3.1 Takeda Company Details
  13.3.2 Takeda Business Overview and Its Total Revenue
  13.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Introduction
  13.3.4 Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
  13.3.5 Takeda Recent Development
13.4 Mitsubishi Chemical
  13.4.1 Mitsubishi Chemical Company Details
  13.4.2 Mitsubishi Chemical Business Overview and Its Total Revenue
  13.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Introduction
  13.4.4 Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
  13.4.5 Mitsubishi Chemical Recent Development
13.5 Avanir Pharmaceuticals
  13.5.1 Avanir Pharmaceuticals Company Details
  13.5.2 Avanir Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
  13.5.4 Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
  13.5.5 Avanir Pharmaceuticals Recent Development
13.6 Dong-A Pharmaceutical Co., Ltd.
  13.6.1 Dong-A Pharmaceutical Co., Ltd. Company Details
  13.6.2 Dong-A Pharmaceutical Co., Ltd. Business Overview and Its Total Revenue
  13.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Introduction
  13.6.4 Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
  13.6.5 Dong-A Pharmaceutical Co., Ltd. Recent Development
13.7 Immune Pharmaceuticals
  13.7.1 Immune Pharmaceuticals Company Details
  13.7.2 Immune Pharmaceuticals Business Overview and Its Total Revenue
  13.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
  13.7.4 Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
  13.7.5 Immune Pharmaceuticals Recent Development
13.8 MediciNova
  13.8.1 MediciNova Company Details
  13.8.2 MediciNova Business Overview and Its Total Revenue
  13.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Introduction
  13.8.4 MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
  13.8.5 MediciNova Recent Development
13.9 Sangamo BioSciences
  13.9.1 Sangamo BioSciences Company Details
  13.9.2 Sangamo BioSciences Business Overview and Its Total Revenue
  13.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Introduction
  13.9.4 Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
  13.9.5 Sangamo BioSciences Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Diabetic Neurological Disorder Therapeutic Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetic Neurological Disorder Therapeutic Drug Revenue
Table 3. Ranking of Global Top Diabetic Neurological Disorder Therapeutic Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Capsule
Table 6. Key Players of Pills
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Diabetic Neurological Disorder Therapeutic Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Diabetic Neurological Disorder Therapeutic Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Diabetic Neurological Disorder Therapeutic Drug Players to Combat Covid-19 Impact
Table 13. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Regions (2015-2020)
Table 17. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Diabetic Neurological Disorder Therapeutic Drug Market Growth Strategy
Table 23. Main Points Interviewed from Key Diabetic Neurological Disorder Therapeutic Drug Players
Table 24. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2015-2020) (Million US$)
Table 25. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players (2015-2020)
Table 26. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2019)
Table 27. Global Diabetic Neurological Disorder Therapeutic Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
Table 30. Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020) (Million US$)
Table 33. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Type (2015-2020)
Table 34. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2021-2026)
Table 35. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Application (2015-2020)
Table 36. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020) (Million US$)
Table 37. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Application (2021-2026)
Table 38. North America Key Players Diabetic Neurological Disorder Therapeutic Drug Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Diabetic Neurological Disorder Therapeutic Drug Market Share (2019-2020)
Table 40. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020) (Million US$)
Table 41. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2015-2020)
Table 42. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020) (Million US$)
Table 43. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2015-2020)
Table 44. Europe Key Players Diabetic Neurological Disorder Therapeutic Drug Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Diabetic Neurological Disorder Therapeutic Drug Market Share (2019-2020)
Table 46. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2015-2020)
Table 48. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2015-2020)
Table 50. China Key Players Diabetic Neurological Disorder Therapeutic Drug Revenue (2019-2020) (Million US$)
Table 51. China Key Players Diabetic Neurological Disorder Therapeutic Drug Market Share (2019-2020)
Table 52. China Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020) (Million US$)
Table 53. China Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2015-2020)
Table 54. China Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020) (Million US$)
Table 55. China Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2015-2020)
Table 56. Japan Key Players Diabetic Neurological Disorder Therapeutic Drug Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Diabetic Neurological Disorder Therapeutic Drug Market Share (2019-2020)
Table 58. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2015-2020)
Table 60. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Diabetic Neurological Disorder Therapeutic Drug Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Diabetic Neurological Disorder Therapeutic Drug Market Share (2019-2020)
Table 64. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2015-2020)
Table 66. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2015-2020)
Table 68. India Key Players Diabetic Neurological Disorder Therapeutic Drug Revenue (2019-2020) (Million US$)
Table 69. India Key Players Diabetic Neurological Disorder Therapeutic Drug Market Share (2019-2020)
Table 70. India Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020) (Million US$)
Table 71. India Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2015-2020)
Table 72. India Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020) (Million US$)
Table 73. India Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Diabetic Neurological Disorder Therapeutic Drug Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Diabetic Neurological Disorder Therapeutic Drug Market Share (2019-2020)
Table 76. Central & South America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2015-2020)
Table 78. Central & South America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2015-2020)
Table 80. AstraZeneca Company Details
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Product
Table 83. AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020) (Million US$)
Table 84. AstraZeneca Recent Development
Table 85. Johnson & Johnson Company Details
Table 86. Johnson & Johnson Business Overview
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020) (Million US$)
Table 89. Johnson & Johnson Recent Development
Table 90. Takeda Company Details
Table 91. Takeda Business Overview
Table 92. Takeda Product
Table 93. Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020) (Million US$)
Table 94. Takeda Recent Development
Table 95. Mitsubishi Chemical Company Details
Table 96. Mitsubishi Chemical Business Overview
Table 97. Mitsubishi Chemical Product
Table 98. Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020) (Million US$)
Table 99. Mitsubishi Chemical Recent Development
Table 100. Avanir Pharmaceuticals Company Details
Table 101. Avanir Pharmaceuticals Business Overview
Table 102. Avanir Pharmaceuticals Product
Table 103. Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020) (Million US$)
Table 104. Avanir Pharmaceuticals Recent Development
Table 105. Dong-A Pharmaceutical Co., Ltd. Company Details
Table 106. Dong-A Pharmaceutical Co., Ltd. Business Overview
Table 107. Dong-A Pharmaceutical Co., Ltd. Product
Table 108. Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020) (Million US$)
Table 109. Dong-A Pharmaceutical Co., Ltd. Recent Development
Table 110. Immune Pharmaceuticals Company Details
Table 111. Immune Pharmaceuticals Business Overview
Table 112. Immune Pharmaceuticals Product
Table 113. Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020) (Million US$)
Table 114. Immune Pharmaceuticals Recent Development
Table 115. MediciNova Business Overview
Table 116. MediciNova Product
Table 117. MediciNova Company Details
Table 118. MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020) (Million US$)
Table 119. MediciNova Recent Development
Table 120. Sangamo BioSciences Company Details
Table 121. Sangamo BioSciences Business Overview
Table 122. Sangamo BioSciences Product
Table 123. Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020) (Million US$)
Table 124. Sangamo BioSciences Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Type: 2020 VS 2026
Figure 2. Capsule Features
Figure 3. Pills Features
Figure 4. Other Features
Figure 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application: 2020 VS 2026
Figure 6. Symmetrical Neuropathy Case Studies
Figure 7. Focal and Multifocal Neuropathy Case Studies
Figure 8. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered
Figure 9. Global Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Regions: 2020 VS 2026
Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players in 2019
Figure 14. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2019
Figure 16. North America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AstraZeneca Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Johnson & Johnson Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Takeda Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
Figure 29. Mitsubishi Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Mitsubishi Chemical Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
Figure 31. Avanir Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Avanir Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
Figure 33. Dong-A Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Dong-A Pharmaceutical Co., Ltd. Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
Figure 35. Immune Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Immune Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
Figure 37. MediciNova Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. MediciNova Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
Figure 39. Sangamo BioSciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sangamo BioSciences Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed